Cargando…
Adjuvant radiotherapy shows benefit in selected stage I uterine sarcoma: A risk scoring system based on a population analysis
BACKGROUND: The potential therapeutic benefit of adjuvant radiotherapy for patients with stage I uterine sarcoma has not been clear. In this study, we aimed to develop a risk scoring model to select the subgroup of patients with stage I uterine sarcoma who might benefit from adjuvant radiotherapy. M...
Autores principales: | Huang, Yun‐xia, Lin, Yan‐zong, Li, Yi‐min, Chu, Ke‐xin, Zhou, Yu‐fei, Lin, Li‐mei, Zhou, Rui, Zhang, Zong‐kai, Lin, Qin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302311/ https://www.ncbi.nlm.nih.gov/pubmed/35277934 http://dx.doi.org/10.1002/cam4.4643 |
Ejemplares similares
-
The prognosis factor of adjuvant radiation therapy after surgery in uterine sarcomas
por: Hou, Hai-Ling, et al.
Publicado: (2015) -
Treatment of early uterine sarcomas: disentangling adjuvant modalities
por: Zagouri, Flora, et al.
Publicado: (2009) -
ASO Author Reflections: Benefit of Adjuvant Radiotherapy for Clinical Outcome in Patients with Soft Tissue Sarcoma
por: Haas, R. L., et al.
Publicado: (2018) -
Survival benefit after neoadjuvant or adjuvant radiotherapy for stage II–III gastroesophageal junction adenocarcinoma: A large population-based cohort study
por: Zuo, Zhichao, et al.
Publicado: (2022) -
Prognostic factors and treatment comparison in small cell neuroendocrine carcinoma of the uterine cervix based on population analyses
por: Lin, Li‐mei, et al.
Publicado: (2020)